Nearly half of the world’s population, or 3.5 billion people, suffer from oral diseases, the majority of them in low- and middle-income countries, the World Health Organization said on Thursday.
In the near future, painful jabs and muscle soreness that persists for days could be replaced by new immunization approaches including intradermal delivery, edible and intranasal vaccines.
Understanding and applying health literacy principles is about empowering people to find, discern, and use information to improve their own health, or the health of those they care for. Clear communication, achieved with the support of health literacy principles, makes healthcare spaces more equitable and accessible for everyone.
U.S. President Joe Biden will announce on Friday nearly $1.5 billion to fund access to medications for opioid overdoses, sanctions against traffickers, and increased funding for law enforcement, the White House said.
The company has donated 100,000 courses of its COVID-19 antiviral treatment Paxlovid to a new group aiming to improve access to the drug in low and middle-income countries.
VMLY&R’s Walter Geer shares his take on the industry’s progress over the past several decades, and the importance of technology, brand authenticity, patient access and much more.
While preventive care is vital to the well-being of all types of patients, members of the lesbian, gay, bisexual, transgender and queer and/or questioning community face unique barriers that impact their preventive health awareness and access – setting many of them up for poorer overall health outcomes and even impacting their trust in pharma.
In a perplexing social paradox, diseases that disproportionately affect people of color are frequently also ones that receive less attention from the medical world. Compounding the problem, diseases that affect people across all races often have fewer people of color in clinical trials for new treatments. The reasons for the problem are widely speculated.
An alliance of companies has pledged to ensure equitable access to vaccines and treatments for pandemics, as the friction around intellectual property rights for COVID-19 interventions between the pharmaceutical industry and developing nations endures.
The agency revised its EUA to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid.